Byrna Technologies Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Byrna Technologies Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Nov 30, 2020 | $16.57M | Feb 26, 2021 |
| FY2020 | Nov 30, 2019 | $924.4K | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | $250.2K | May 18, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $118.12M | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | $85.76M | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | $42.64M | Feb 7, 2025 |
| FY2023 | Nov 30, 2022 | $48.04M | Feb 14, 2024 |
| FY2022 | Nov 30, 2021 | $42.16M | Feb 9, 2023 |
| FY2021 | Nov 30, 2020 | $16.57M | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | $924.4K | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | $250.2K | May 18, 2020 |
| FY2018 | Nov 30, 2017 | $292.5K | Mar 1, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Nov 30, 2017 | $292.5K | Mar 15, 2018 |
| FY2017 | Nov 30, 2016 | $154.0K | Mar 15, 2018 |
| FY2016 | Nov 30, 2015 | $151.0K | Mar 13, 2017 |
| FY2015 | Nov 30, 2014 | $42.5K | Feb 29, 2016 |
| FY2014 | Nov 30, 2013 | $30.1K | Oct 20, 2015 |
| FY2013 | Nov 30, 2012 | $0 | Mar 17, 2014 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $71.47M | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | $52.77M | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | $23.65M | Feb 7, 2025 |
| FY2023 | Nov 30, 2022 | $26.28M | Feb 14, 2024 |
| FY2022 | Nov 30, 2021 | $22.89M | Feb 9, 2023 |
| FY2021 | Nov 30, 2020 | $7.51M | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | $149.0K | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | $64.2K | May 18, 2020 |
| FY2018 | Nov 30, 2017 | $101.2K | Mar 1, 2019 |
| FY2017 | Nov 30, 2016 | $59.0K | Mar 15, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $9.69M | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | $12.79M | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | ($8.19M) | Feb 7, 2025 |
| FY2023 | Nov 30, 2022 | ($7.89M) | Feb 14, 2024 |
| FY2022 | Nov 30, 2021 | ($3.28M) | Feb 9, 2023 |
| FY2021 | Nov 30, 2020 | ($12.55M) | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | ($4.41M) | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | ($2.15M) | May 18, 2020 |
| FY2018 | Nov 30, 2017 | ($2.80M) | Mar 1, 2019 |
| FY2017 | Nov 30, 2016 | ($1.92M) | Mar 15, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $11.84M | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | $6.67M | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | ($7.79M) | Feb 7, 2025 |
| FY2023 | Nov 30, 2022 | ($7.73M) | Feb 14, 2024 |
| FY2022 | Nov 30, 2021 | ($3.29M) | Feb 9, 2023 |
| FY2021 | Nov 30, 2020 | ($4.31M) | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | ($3.29M) | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | ($2.04M) | May 18, 2020 |
| FY2018 | Nov 30, 2017 | ($1.92M) | Mar 1, 2019 |
| FY2017 | Nov 30, 2016 | ($1.69M) | Mar 15, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $300.0K | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | $600.0K | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | $600.0K | Feb 7, 2025 |
| FY2023 | Nov 30, 2022 | $500.0K | Feb 14, 2024 |
| FY2022 | Nov 30, 2021 | $300.0K | Feb 9, 2023 |
| FY2021 | Nov 30, 2020 | $40.0K | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | $158.1K | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | $164.2K | May 18, 2020 |
| FY2013 | Nov 30, 2013 | $0 | Mar 17, 2014 |
| FY2013 | Nov 30, 2012 | ($215.1K) | Mar 17, 2014 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($1.57M) | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | $11.74M | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | $3.89M | Feb 7, 2025 |
| FY2023 | Nov 30, 2022 | ($13.83M) | Feb 14, 2024 |
| FY2022 | Nov 30, 2021 | ($4.44M) | Feb 9, 2023 |
| FY2021 | Nov 30, 2020 | $2.54M | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | ($3.77M) | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | ($1.60M) | May 18, 2020 |
| FY2018 | Nov 30, 2017 | ($1.47M) | Mar 1, 2019 |
| FY2017 | Nov 30, 2016 | ($1.66M) | Mar 15, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $7.62M | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | $2.35M | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | $903.0K | Feb 7, 2025 |
| FY2023 | Nov 30, 2022 | $3.25M | Feb 14, 2024 |
| FY2022 | Nov 30, 2021 | $1.84M | Feb 9, 2023 |
| FY2021 | Nov 30, 2020 | $1.43M | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | $246.0K | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | $311.5K | May 18, 2020 |
| FY2018 | Nov 30, 2017 | $21.8K | Mar 1, 2019 |
| FY2017 | Nov 30, 2016 | $0 | Mar 15, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $84.49M | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | $71.92M | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | $52.31M | Feb 7, 2025 |
| FY2023 | Nov 30, 2022 | $57.05M | Feb 14, 2024 |
| FY2022 | Nov 30, 2021 | $75.31M | Feb 9, 2023 |
| FY2021 | Nov 30, 2020 | $21.22M | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | $3.57M | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | $2.66M | May 18, 2020 |
| FY2018 | Nov 30, 2017 | $2.19M | Mar 1, 2019 |
| FY2017 | Nov 30, 2016 | $370.1K | Mar 15, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $18.73M | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | $17.55M | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | $10.00M | Feb 7, 2025 |
| FY2023 | Nov 30, 2022 | $11.06M | Feb 14, 2024 |
| FY2022 | Nov 30, 2021 | $9.22M | Feb 9, 2023 |
| FY2021 | Nov 30, 2020 | $12.81M | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | $5.55M | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | $2.50M | May 18, 2020 |
| FY2018 | Nov 30, 2017 | $1.87M | Mar 1, 2019 |
| FY2017 | Nov 30, 2016 | $1.36M | Mar 15, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $65.76M | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | $54.37M | Feb 5, 2026 |
| FY2025 | Nov 30, 2023 | $42.32M | Feb 5, 2026 |
| FY2024 | Nov 30, 2022 | $45.99M | Feb 7, 2025 |
| FY2023 | Nov 30, 2021 | $66.10M | Feb 14, 2024 |
| FY2021 | Nov 30, 2020 | $8.41M | Feb 11, 2022 |
| FY2022 | Nov 29, 2020 | $8.41M | Feb 9, 2023 |
| FY2021 | Nov 30, 2019 | ($1.98M) | Feb 11, 2022 |
| FY2020 | Nov 30, 2018 | $157.0K | Feb 26, 2021 |
| FY2019 | Nov 30, 2017 | ($326.6K) | May 18, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $2.26M | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | $2.26M | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | $2.26M | Feb 7, 2025 |
| FY2023 | Nov 30, 2022 | $2.26M | Feb 14, 2024 |
| FY2022 | Nov 30, 2021 | $816.0K | Feb 9, 2023 |
| FY2021 | Nov 30, 2020 | $651.0K | Feb 11, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($47.10M) | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | ($56.78M) | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | ($69.58M) | Feb 7, 2025 |
| FY2023 | Nov 30, 2022 | ($61.38M) | Feb 14, 2024 |
| FY2022 | Nov 30, 2021 | ($53.50M) | Feb 9, 2023 |
| FY2021 | Nov 30, 2020 | ($50.22M) | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | ($37.66M) | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | ($33.25M) | May 18, 2020 |
| FY2018 | Nov 30, 2017 | ($31.10M) | Mar 1, 2019 |
| FY2017 | Nov 30, 2016 | ($28.30M) | Mar 15, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $13.73M | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | $16.83M | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | $20.50M | Feb 7, 2025 |
| FY2023 | Nov 30, 2022 | $20.07M | Feb 14, 2024 |
| FY2022 | Nov 30, 2021 | $56.31M | Feb 9, 2023 |
| FY2021 | Nov 30, 2020 | $3.18M | Feb 11, 2022 |
| FY2019 | Nov 30, 2019 | $1.17M | May 18, 2020 |
| FY2019 | Nov 30, 2018 | $1.18M | May 18, 2020 |
| FY2019 | Nov 30, 2017 | $1.97M | May 18, 2020 |
| FY2018 | Nov 30, 2016 | $192.8K | Mar 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Nov 30, 2019 | $6.46M | May 18, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 0 | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | 0 | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | 0 | Feb 7, 2025 |
| FY2023 | Nov 30, 2022 | 0 | Feb 14, 2024 |
| FY2022 | Nov 30, 2021 | 0 | Feb 9, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 0 | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | 0 | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | 0 | Feb 7, 2025 |
| FY2012 | Nov 30, 2012 | 0 | Feb 28, 2013 |
| FY2012 | Nov 30, 2011 | 0 | Feb 28, 2013 |
| FY2011 | Nov 30, 2010 | 0 | Mar 13, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 22.68M | Feb 5, 2026 |
| FY2025 | Nov 30, 2024 | 22.50M | Feb 5, 2026 |
| FY2024 | Nov 30, 2023 | 22.00M | Feb 7, 2025 |
| FY2023 | Nov 30, 2022 | 21.85M | Feb 14, 2024 |
| FY2022 | Nov 30, 2021 | 23.75M | Feb 9, 2023 |
| FY2021 | Nov 30, 2020 | 14.85M | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | 104.02M | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | 101.98M | May 18, 2020 |
| FY2018 | Nov 30, 2017 | 93.01M | Mar 1, 2019 |
| FY2017 | Nov 30, 2016 | 55.10M | Mar 15, 2018 |